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2. General Experimental Procedures.
Measurement of Two-photon Cross Section.
The two-photon cross section (σ) was determined by using a femtosecond (fs) fluorescence measurement technique. DFHBMSI (3 μM), DFHBSI (3 μM) or DFHBFSI (3 μM) was mixed with NG16 (15 μM) in Tris-HCl buffer (25 mM Tris, 100
mM KCl, 50 mM MgCl2 and pH 8.0), and then the two-photon fluorescence spectrum of the sample was measured from 710 nm to 870 nm by using Rhodamine 6G in MeOH (σ = 70 GM at 810 nm) as the standard. The two-photon cross-section was calculated by using the Equation S1, [1] 
where the subscripts t and r stand for the sample and reference molecules. F is the average fluorescence intensity integrated from 2PE spectrum; n is the refractive index of the solvent; C is the concentration; Ф is the quantum yield, and σr is the two-photon cross-section of the reference molecule.
pKa Measurements.
For the pKa measurement, HBSI (20 μM) was prepared in buffer with pH range of 5 -12, and then absorbance values at 493 nm were measured. Similarly, for the pKa measurements of DFHBSI, HBNI and DFHBNI (20 μM), the pH ranges of buffer solutions were 3 -12, 5 -12 and 3 -12, and absorbance values at 503 nm, 496 nm and 520 nm were recorded, respectively. The half-maximal value of the chromophores was calculated based on the plot of absorbance value versus pH.
Quantum Yield Calculations.
The quantum yield was calculated using the Equation S2, [2] 
where ΦF is the fluorescence quantum yield; A is the absorbance at the excitation wavelength; F is the area under the corrected emission curve, and n is the refractive S18 index of the solvent. Subscripts S and X refer to the standard and the unknown, respectively. The solutions of synthesized RFP chromophore analogues, rhodamine 6G, Cy5 and standards were kept absorptions below 0.05.
Dissociation Constant Measurements.
The Kd of RFP analogues to the respective G-quadruplexes were analyzed by one site specific binding model based the Equation S3.
[3]
Where Y represents the fluorescence fold change of RFP analogues; Ymax is the fluorescence fold change of RFP analogue when saturated with G-quadruplex, and X is the concentration of the G-quadruplex (NG16).
Photo-bleaching Analysis
Aqueous droplets of Lyso-Tracker Red (1 µM), mCherry (1 µM), and DFHBFSI-NG16 
Molecular Modeling.
The coordinates of parallel G-quadruplex NG16 (PDB ID: 2LXV) were retrieved from Protein Data Bank. [4, 5] 2LXV is dimeric and only the first chain was used. NG16 and the phenolate form of DFHBFSI were prepared by AutDockTools and molecular interactions between them were studied by docking simulations via AutoDock 4.2.6
with the Lamarckian genetic algorithm. [6] Since it is possible for DFHBFSI to interact with NG16 via end stacking at either the 3' end or 5' end and groove-binding at all four sides, the most energetically favorable binding mode was adopted as the starting conformation for each possible binding mode for the following Molecular Dynamics (MD) simulations. The phenolate DFHBFSI without G-quadruplex was also simulated S19 for comparison. There are seven simulations in total (the DFHBFSI alone, the 3' end stacking simulation, 5' end stacking simulation, the side1, side2, side3 and side4 simulations for the groove binding simulations). The force field parameters of phenolate DFHBFSI were developed by following the CGenFF protocols and the c36 version of CHARMM DNA force field parameters were used for G-quadruplex. [7, 8] Each system was then solvated using TIP3P water molecules, which were extended up to 10 Å in a rectangular box. The systems were neutralized by adding K + ions. The solvated systems were subjected to equilibration followed by 100 ns of MD run with coordinates saved for every 10 picoseconds. The coordinates of hybrid G4 HT and antiparallel G4 TBA were retrieved based on PDB ID 2GKU and 5MJX. [9, 10] The binding modes of DFHBFSI with these two G-quadruplexes were studied in the same protocol as 2LXV. The binding free energies between the DFHBFSI ligand and the Gquadruplex were calculated by MM/PBSA (8) method in CHARMM. [11] All the figures were rendered using PyMOL 1.3.
[12]
DFT Calculations.
The density functional theory method with CAM-B3LYP method was applied to the geometry optimization of DFHBFSI complex with 6-311++G** basis set. [13, 14] Time dependent density functional theory (TDDFT) is one of the most popular approaches for the calculation of excitation energies in quantum chemistry because of its efficiency and accuracy [15, 16] . Since conventional TDDFT calculations underestimate chargetransfer excitation energies, long-range-corrected TDDFT (LRC-TDDFT) method was employed with CAM-B3LYP functional and 6-311++G** basis set. Potential energy surfaces of S1 and S0 along the phenoxy-twisted photoisomerization pathway were carried out at the LRC-TDDFT/6-311++G** level. The rotation step is 5º in the range of 0º -90º , and 10º after 90º . Coordinate-driving potential surface scans were generated by fixing the bridge dihedral angle ( Figure 5A ) and minimizing all other degrees of freedom subject to this constraint. All geometry optimization and potential energy surface calculations were performed with the Gaussian 09 software package. [17] Based on results of Mulliken charge population analyses, the spatial distribution of electron S20 density was visualized using the program VMD (version 1.9.1). [18] 2.8 Cell Culture.
CCRF-CEM, Ramos and A549 cells were cultured in RPMI 1640 (Hyclone) with 10% fetal bovine serum (Gibco), 100 U/mL penicillin and 100 ug/mL streptomycin (Hyclone). HepG2、HEK-293T cells were cultured in the high glucose (4.5 g/L)
version of DMEM (Hyclone) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 ug/mL streptomycin. HT-29 cells were cultured in McCoy's 5a
Medium Modified (Hyclone) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 ug/mL streptomycin. All cells were maintained at 37 ° C in a 5% CO2 atmosphere.
Cytotoxicity Measurements.
Cytotoxicity of DFHBFSI was determined by CCK-8 assays. Before the experiment, 
Construction of Plasmids and Real-time Quantitative Reverse Transcription PCR
Gene sequences of EGFP and PTK7 were PCR amplified and cloned into a pCDN3.1
backbone to obtain plasmids pCDN3.1-egfp and pCDN3.1-ptk7, respectively. The 
Flow Cytometry and Confocal Laser Scanning Microscopy Assay
The sgc8 probe (500 nM) was incubated with 5 × 10 5 CCRF-CEM cells or Ramos cells in DPBS for 30 min, and washed by 0.2 mL DPBS twice. Then, the cells were incubated with reporter probe (500 nM) and DFHBFSI (500 nM) in buffer (DPBS with 10 mM
KCl and 30 mM MgCl2) for 10 min. After that, the sample was washed and re-dispersed by 0.2 mL DPBS with 10 mM KCl and 30 mM MgCl2. The above steps were performed at 4 °C . Finally, the cells were subjected to flow cytometry (Beckman Coulter Gallios， USA) at RT, and the data was obtained by counting 20000 events.
Cells (5×10 5 ) were incubate with their corresponding aptamer probes (500 nM of sgc8, SL1 or SYL3C) in DPBS for 30 min, and washed by 0.2 mL DPBS twice. After that, the cells were incubated with reporter probe (500 nM) and DFHBFSI (500 nM) in buffer (DPBS with 10 mM KCl and 30 mM MgCl2) for 10 min. The steps prior to confocal imaging were performed at 4 °C . Then one-photon and two-photon imaging were performed on Nikon A1 and Olympus FV1000 confocal laser scanning microscopy at RT, respectively.
Co-localization of two fluorescent channels in confocal images was determined by
Manders' overlap coefficient (R) [19] using the Image-Pro Plus software (Media Cybernetics. Inc). An overlap coefficient higher than 0.6 indicates strong colocalization. Values are means with SD (n = 5).
Tissue Imaging.
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Frozen tissue slices were prepared from CCRF-CEM cell xenograft mice. To rule out nonspecific binding, frozen tissue slices were incubated in 1 μM random sequences for 5 min. Then, sgc8 probe (500 nM) was incubated with the sections in DPBS for 30 min.
Each frozen tissue section was washed with 0.5 mL DPBS for three times. Finally, tissue section was incubated with reporter probe (500 nM) and DFHBFSI (500 nM) in buffer (DPBS with 10 mM KCl and 30 mM MgCl2) for 1 h. After the incubation, the tissue section was washed with 0.5 mL buffer (DPBS with 10 mM KCl and 30 mM MgCl2) three times and then observing under a fluorescence microscope.
S23
3. Synthesis and Characterization. [20] Hexamethylenetetramine (9.5 g, 67.76 mmol), 2, 6-difluorophenol (8 g, 61.6 mmol)
Synthesis of 2, 6-difluoro-4-hydroxybenzaldehyde (1a)
and TFA (90 mL) were stirred at 120 °C under argon atmosphere for 12 h. After allowing the reaction to cool to room temperature, the solvent was removed under vacuum condition. The crude product was re-dissolved in dichloromethane, and washed by acidified ultrapure water (pH 1.0). The aqueous layer was separated, extracted with dichloromethane (3×50 mL). And the separated organic layer was dried with anhydrous magnesium sulfate and evaporated in vacuum to afford a white solid (9.7 g, yield 70%). 
Synthesis of (Z)-2, 6-difluoro-4-((2-methyl-5-oxooxazol-4(5H)-ylidene) methyl) phenyl acetate (2a)
N-Acetylglycine (1.17 g, 10 mmol), anhydrous sodium acetate (0.82 g, 10 mmol), 2,6-difluoro-4-hydroxybenzaldehyde (1.58 g, 10 mmol), and acetic anhydride (10 mL)
were stirred at 120 °C for 4 h. After allowing the reaction to cool to room temperature, the resulting crude solid was then washed with a small amount of cold ethanol, hot water dried to afford the primary product which was recrystallized from ethanol, yielding a yellow solid (2.08 g, yield 74%), without purification and characterization for the next step. [21] Compound 2a (1 g, 3 .56 mmol), potassium carbonate (700 mg, 5.06 mmol), 40%
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Synthesis of (Z)-4-(3, 5-difluoro-4-hydroxybenzylidene)-1, 2-dimethyl-1H-imidazol-5(4H)-one (3a)
aqueous methylamine (2 mL), and ethanol (20 mL) were stirred at 120 °C for 4 h. The mixture was cooled to room temperature, the precipitate was filtered and washed briefly with cold ethanol. The precipitate was then re-dissolved in a 1:1 mixture of ethyl acetate and aqueous sodium acetate solution (500 mM, pH 3.0). The organic layer was separated, dried with anhydrous magnesium sulfate and the solvent was evaporated in vacuums to afford an orange solid (553 mg, yield 62% 
Synthesis of (4Z)-(3, 5-difluoro-4-hydroxybenzylidene)-2-((E)-2,
5-difluorostyryl)-1-methyl-1H-imidazol-5(4H)-one (DFHBFSI).
Compound 3a (176 mg, 0.7 mmol), anhydrous zinc chloride (95 mg, 0.7 mmol), 2,5-difluorobenzaldehyde (114 mg, 0.8 mmol), and THF (15 mL) were stirred at 80 °C for 6 h. After allowing the reaction to cool to room temperature the crude product was purified by silica gel column chromatography (PE: EtOAc 
Synthesis of (4Z)-(3, 5-difluoro-4-hydroxybenzylidene)-2-((E)-4-methoxystyryl)-1-methyl-1H-imidazol-5(4H)-one (DFHBMSI).
Compound 3a (176 mg, 0.7 mmol), anhydrous zinc chloride (95 mg, 0.7 mmol), 4-methoxybenzaldehyde (108.8 mg, 0.8 mmol), and THF (15 mL) were stirred at 80 °C for 6 h. After allowing the reaction to cool to room temperature the crude product was purified by silica gel column chromatography (PE: EtOAc 
Synthesis of (4Z)-(3, 5-difluoro-4-hydroxybenzylidene)-1-methyl-
2-((E)-styryl)-1H-imidazol-5(4H)-one (DFHBSI).
Compound 3a (176 mg, 0.7 mmol), anhydrous zinc chloride (95 mg, 0.7 mmol), benzaldehyde (84.8mg, 0.8 mmol), and THF (15 mL) were stirred at 80 °C for 6 h.
After allowing the reaction to cool to room temperature the crude product was purified by silica gel column chromatography (PE:EtOAc = 3:1, v/v) to afford a yellow solid (123.4 mg, yield 52% 
Synthesis of (4Z)-(3, 5-difluoro-4-hydroxybenzylidene)-1-methyl-
2-((E)-2-(naphthalen-1-yl) vinyl)-1H-imidazol-5(4H)-one (DFHBNI).
Compound 3a (176 mg, 0.7 mmol), anhydrous zinc chloride (95 mg, 0.7 mmol), 1-naphthaldehyde (124.8 mg, 0.8 mmol) and THF (15 mL) were stirred at 80 °C for 6 h.
After allowing the reaction to cool to room temperature, the crude product was purified 
Synthesis of (4Z)-(3, 5-difluoro-4-hydroxybenzylidene)-2-((E)-4-(dimethylamino)styryl)-1-methyl-1H-imidazol-5(4H)-one (DFHBASI).
Compound 3a (176 mg, 0.7 mmol), anhydrous zinc chloride (95 mg, 0. 
Synthesis of (4Z)-(4-hydroxybenzylidene)-1-methyl-2-((E)-styryl)-1H-imidazol-5(4H)-one (1b)
S28 N-Acetylglycine (11. 
Synthesis of (4Z)-(4-hydroxybenzylidene)-1-methyl-2-((E)-styryl)-1H-imidazol-5(4H)-one (HBSI).
Compound 2b (176 mg, 0.7 mmol), anhydrous zinc chloride (95 mg, 0.7 mmol), benzaldehyde (84.8 mg, 0.8 mmol), and THF (15 mL) were stirred at 80 °C for 6 h.
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After allowing the reaction to cool to room temperature the crude product was purified by silica gel column chromatography (PE: EtOAc 
Synthesis of (4Z)-(4-hydroxybenzylidene)-1-methyl-2-((E)-2-(naphthalen-1-yl) vinyl)-1H-imidazol-5(4H)-one (HBNI).
Compound 2b (176 mg, 0. 
